FDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases RLT...
APPLY-PNH extension data show that continuous Fabhalta® (iptacopan) treatment in adults with paroxysmal...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.